The company is currently raising growth capital to accelerate manufacturing and commercialization of its products and services into the life sciences market having confirmed the large opportunity and established traction with pharmaceutical and diagnostic companies.
Interested in Investing?
Contact: Juan Diaz-Mochon and David Whitcombe, co-CEOs;
emails: juan@destinagenomics.com & david@destinagenomics.com